Menu Search
Equities

Silence Therapeutics PLC

SLN:NMQ

Silence Therapeutics PLC

Actions
  • Price (USD)23.00
  • Today's Change0.06 / 0.26%
  • Shares traded121.16k
  • 1 Year change+322.02%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Institutional shareholders

32.21%Per cent of shares held by top holders
HolderShares% Held
Invus Public Equities Advisors LLCas of 31 Mar 20242.78m5.98%
Lombard Odier Asset Management (USA) Corp.as of 31 Mar 20242.39m5.14%
Lombard Odier Asset Management (Europe) Ltd.as of 31 Mar 20242.24m4.81%
Redmile Group LLCas of 31 Mar 20242.03m4.36%
Deep Track Capital LPas of 31 Mar 20241.64m3.54%
Logos Global Management LPas of 31 Mar 20241.48m3.17%
Janus Henderson Investors US LLCas of 31 Mar 2024625.86k1.35%
Cormorant Asset Management LPas of 31 Mar 2024625.00k1.34%
Adage Capital Management LPas of 31 Mar 2024600.00k1.29%
Aquilo Capital Management LLCas of 31 Mar 2024574.21k1.24%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.